Clinical trial
Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or…
NCT00004250 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004250 |
|---|---|
| Title | Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery |
| Official title | A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin), Sarcoma |
| Intervention type | Biological, Drug |
| Interventions | dactinomycin, isolated limb perfusion, melphalan |
| Enrollment | 35 |
| Start date | Aug 1, 1999 |
| Primary completion | Jun 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: